Chimeric Therapeutics Limited (CHMMF)
CHMMF Stock Price Chart
Explore Chimeric Therapeutics Limited interactive price chart. Choose custom timeframes to analyze CHMMF price movements and trends.
CHMMF Company Profile
Discover essential business fundamentals and corporate details for Chimeric Therapeutics Limited (CHMMF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Nov 2022
Employees
—
CEO
Rebecca McQualter
Description
Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies in oncology in Australia. The company develops CHM 0201 (core NK platform) that is in phase I clinical trial for treating solid tumors and hematological malignancies; and CHM 1101 (CLTX CAR T), which is in phase I clinical trial for treating patients with MMP2+ recurrent or progressive glioblastoma. It is also developing CHM 0301 for blood cancers; CHM 1301 (CLTX CAR NK) and CHM 2301 (CDH17 CAR NK) for solid tumors; CHM 1101 (CLTX CAR T) for melanoma, colorectal, and prostate; and CHM 2101 (CDH17 CAR T) for neuroendocrine, colorectal, pancreatic, and gastric. The company was incorporated in 2020 and is based in Carlton, Australia.
CHMMF Financial Timeline
Browse a chronological timeline of Chimeric Therapeutics Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 Feb 2026
Earnings released on 29 Aug 2025
Earnings released on 26 Feb 2025
EPS came in at -$0.00 .
Earnings released on 30 Aug 2024
EPS came in at -$0.01 surpassing the estimated -$0.02 by +22.99%.
Earnings released on 30 Apr 2024
EPS came in at $0.00 surpassing the estimated -$0.01 by +122.98%, while revenue for the quarter reached $3.73M .
Earnings released on 30 Jun 2023
EPS came in at -$0.01 surpassing the estimated -$0.01 by +15.52%, while revenue for the quarter reached $937.46K .
Earnings released on 28 Feb 2023
EPS came in at -$0.01 surpassing the estimated -$0.03 by +63.83%, while revenue for the quarter reached $2.06M .
Earnings released on 30 Sept 2022
EPS came in at -$0.01 , while revenue for the quarter reached $899.72K .
Earnings released on 27 Feb 2022
EPS came in at -$0.02 .
Earnings released on 30 Aug 2021
EPS came in at -$0.03 .
Earnings released on 26 Feb 2021
EPS came in at -$0.01 .
CHMMF Stock Performance
Access detailed CHMMF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.